Return to News

COSMIC News

A COSMIC Announcement

7 Jan 2021

We are excited to announce our recent commercial distribution partnership with Qiagen GmbH.

As a result of this partnership, the revenue generated from our Qiagen partnership will ensure COSMIC can continue sustaining and maintaining our valuable resource and enable COSMIC to provide increased resources to the scientific community.

COSMIC will remain part of Genome Research Limited, a not-for-profit organisation, and will continue to reinvest the profits from commercial licensing revenues into the development of the COSMIC database.

Dr Simon Forbes Director of COSMIC quote


Who are Qiagen?
Qiagen are a global corporation supporting 500,000 customers worldwide and are a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Through its Digital Insights business unit, they deliver expert curated genomic and clinical knowledge, software and services for scientists and clinicians to improve insights, accelerate decision and deliver better outcomes.

Jonathan Sheldon Senior VP Qiagen.png



How does it impact you?
Under the multi-year agreement, QIAGEN will leverage its experienced software sales team and global network to grow the adoption and utilisation of COSMIC for its commercial customers.

COSMIC will remain part of Genome Research Limited, a not-for-profit organisation, and will continue to reinvest the profits from commercial licensing revenues into the development of the COSMIC database.


Academic and non-commercial use
Access to COSMIC will continue to be freely available from the Genome Research Limited to researchers for academic and non-commercial use, as before. All non-commercial enquiries to the COSMIC helpdesk will be handled by the COSMIC team, as before at cosmic@sanger.ac.uk.


Commercial use
Existing commercial licenses will be assigned to Qiagen who will take over the commercial relationship and any ongoing support, with assistance from the COSMIC team.

Any prospective customers will be transferred to Qiagen, who will be in contact to progress the discussions.

Any new customers wishing to use COSMIC for commercial use, will need to contact Qiagen via bioinformaticssales@qiagen.com.


If you would like to find out more about the Qiagen commercial distribution partnership, please access the Qiagen press release.

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations

IWD24

Women in STEM

IT

computational biology

STEM career

computer science

v100

cancer mutation census

genetic oncology